Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation

2014 ◽  
Vol 44 (12) ◽  
pp. 1259-1264 ◽  
Author(s):  
Tomokazu Kawaoka ◽  
Shoichi Takahashi ◽  
Yumiko Tatsukawa ◽  
Akira Hiramatsu ◽  
Nobuhiko Hiraga ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Hepatitis C ◽  
Triple Therapy ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Pegylated Interferon ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Recurrent Hepatitis ◽  
Recurrent Hepatitis C

scholarly journals Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation

2016 ◽  
Vol 46 (11) ◽  
pp. 1118-1128 ◽  
Author(s):  
Masahiro Shinoda ◽  
Hirotoshi Ebinuma ◽  
Osamu Itano ◽  
Yoshiyuki Yamagishi ◽  
Hideaki Obara ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Hepatitis C ◽  
Triple Therapy ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Pegylated Interferon ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Recurrent Hepatitis ◽  
Recurrent Hepatitis C

scholarly journals Telaprevir versus simeprevir for the treatment of recurrent hepatitis C after living donor liver transplantation

2015 ◽  
Vol 46 (3) ◽  
pp. E136-E145 ◽  
Author(s):  
Toru Ikegami ◽  
Tomoharu Yoshizumi ◽  
Yoshihro Yoshida ◽  
Takeshi Kurihara ◽  
Norifumi Harimoto ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Hepatitis C ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Recurrent Hepatitis ◽  
Recurrent Hepatitis C
Sign in / Sign up

Export Citation Format

Share Document